Clever Leaves Holdings Inc. CLVR CLVRW announced that its partner, Peruvian medicinal cannabis company Anden Naturals, has obtained the sanitary registration for the finished product, “Andenol 50,” a 5% THC dominant oral solution produced by Clever Leaves in Colombia and sold under the Anden Naturals brand in Peru.
According to the company Andenol 50, is Anden Naturals’ first THC dominant product to obtain sanitary registration for its commercialization as a finished product and is considered to be a “phytotherapeutic” product, by the Peruvian health authority and indicating passage of all quality inspections. Anden Naturals manufactures and markets medicinal cannabis products in Peru through magistral formulations as well as finished products imported from other countries. The company distributes medical cannabis products through its own pharmacies in the country.
“Our purpose at Clever Leaves is to produce the highest quality medical cannabis products for ourselves, our partners, and most importantly, for the millions of medical cannabis patients worldwide. The fact that Anden Naturals is the very first to obtain this sanitary registration in Peru is further proof that we are living up to our incredibly high standards and those of patients across the globe,” stated Andres Fajardo, CEO of Clever Leaves. “Due to the product’s higher THC content, authorities are more demanding in granting the registration and there is greater control over its use, prescription, and commercialization. We are proud to be the leader in setting the standard for every market in which we operate.”
The initial shipment of 1,000 units is set for Q1 of 2023 and the potential market is expected to be 30,000 registered patients, according to data as of August 2022.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Related News
Clever Leaves To Grow & Commercialize House Of Kush THC Flower For International Cannabis Markets
Cannabis Company Sannabis Partners With Occupational Health Services Provider In Colombia
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.